Sodium molybdate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Sodium molybdate
DrugBank Accession Number
DB14496
Background

Not Available

Type
Small Molecule
Groups
Approved, Experimental
Structure
Weight
Average: 205.93
Monoisotopic: 207.864602
Chemical Formula
MoNa2O4
Synonyms
  • Anhydric sodium molybdate
  • Molybdenum (as sodium)
  • Sodium molybdate (anhydrous)
  • Sodium molybdate(VI)
  • Sodium molybdenum oxide

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Diagnostic agentMeckel diverticulum•••••••••••••••••••••
Used in combination as diagnostic agentMeckel diverticulumCombination Product in combination with: Technetium Tc-99m pertechnetate (DB09314), Water (DB09145), Sodium chloride (DB09153)•••••••••••••••••••••••••
Diagnostic agentSalivary gland disorder•••••••••••••••••••••
Diagnostic agentSjögren's syndrome•••••••••••••••••••••
Diagnostic agentThyroid diseases•••••••••••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Sodium molybdate dihydrate8F2SXI170410102-40-6VXPCUCBABLNLFW-UHFFFAOYSA-L
Active Moieties
NameKindUNIICASInChI Key
MolybdateionicO0L10E635214259-85-9MEFBJEMVZONFCJ-UHFFFAOYSA-N
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ADDAMEL INFUSION NSodium molybdate dihydrate (48.5 mcg) + Chromic chloride hexahydrate (53.3 mcg) + Cupric chloride dihydrate (3.4 mg) + Ferric chloride hexahydrate (5.4 mg) + Manganese chloride tetrahydrate (990 mcg) + Potassium Iodide (166 mcg) + Sodium selenite pentahydrate (105 mcg) + Sodium fluoride (2.1 mg) + Zinc chloride (13.6 mg)Solution, concentrateIntravenousFRESENIUS KABI COLOMBIA S.A.S.2006-11-102009-05-08Colombia flag
ADDAMEL NSodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (0.1 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (19.8 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (17.3 mcg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.05 mg/ml)Injection, solution, concentrateIntravenousFresenius Kabi Italia S.R.L.2014-07-082020-05-12Italy flag
ADDAMEL N FOR INFUSIONSodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (0.34 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (99 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (6.9 mcg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.36 mg/ml)InjectionIntravenousFRESENIUS KABI (SINGAPORE) PTE LTD1992-01-31Not applicableSingapore flag
ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSIONSodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (102.3 mcg/ml) + Ferric chloride hexahydrate (540 mcg/ml) + Manganese chloride tetrahydrate (19.79 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (17.29 mcg/ml) + Sodium fluoride (210 mcg/ml) + Zinc chloride (1050 mcg/ml)SolutionIntravenousFRESENIUS KABI (SINGAPORE) PTE LTD2017-07-24Not applicableSingapore flag
Addaven Konzentrat zur Herstellung einer InfusionslösungSodium molybdate dihydrate (4.85 μg/ml) + Chromic chloride hexahydrate (5.33 μg/ml) + Cupric chloride dihydrate (0.1 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (19.8 μg/ml) + Potassium Iodide (16.6 μg/ml) + Sodium selenite (17.3 μg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.05 mg/ml)Injection, solution, concentrateIntravenousFresenius Kabi Austria Gmb H2015-03-02Not applicableAustria flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Addamel NSodium molybdate dihydrate (1.9 ug/1mL) + Chromic chloride hexahydrate (1 ug/1mL) + Cuprous chloride (0.13 mg/1mL) + Ferric chloride (0.11 mg/1mL) + Manganese chloride tetrahydrate (0.027 mg/1mL) + Potassium Iodide (0.013 mg/1mL) + Sodium selenite (3.2 ug/1mL) + Sodium fluoride (0.095 mg/1mL) + Zinc chloride (0.65 mg/1mL)Injection, solutionIntravenousFresenius Kabi USA, LLC2013-05-072017-03-31US flag
ADDAMEL N 20 AMPULSodium molybdate (48.5 mcg/10mL) + Chromic chloride (53.3 mcg/10mL) + Cupric Chloride (3.4 mg/10mL) + Ferric chloride (5.4 mg/10mL) + Manganese chloride (990 mcg/10mL) + Potassium Iodide (166 mcg/10mL) + Sodium selenite (69 mcg/10mL) + Sodium fluoride (2.1 mg/10mL) + Zinc chloride (13.6 mg/10mL)Injection, solutionIntravenousFRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ.2019-04-30Not applicableTurkey flag
ADDAVEN IV INFUZYON ICIN KONSANTRE SOLUSYONSodium molybdate (48.5 mcg/10mL) + Chromic chloride (53.3 mcg/10mL) + Cupric Chloride (1.02 mg/10mL) + Ferric chloride (5.4 mg/10mL) + Manganese chloride (198 mcg/10mL) + Potassium Iodide (166 mcg/10mL) + Sodium selenite (173 mcg/10mL) + Sodium fluoride (2.1 mg/10mL) + Zinc chloride (10.5 mg/10mL)Injection, solutionIntravenousFRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ.2016-09-062022-11-10Turkey flag
Tricare Prenatal 2-part Daily Prenatal Vitamin SystemSodium molybdate (.0375 mg/1) + Ascorbic acid (30 mg/1) + Biotin (.150 mg/1) + Cholecalciferol (400 [iU]/1) + Chromium Cr-51 chloride (.060 mg/1) + Copper gluconate (1 mg/1) + Cyanocobalamin (.125 mg/1) + Doconexent (150 1/1) + Ferric pyrophosphate (4.5 mg/1) + Icosapent (37.5 1/1) + Levomefolic acid (1 mg/1) + Manganese citrate decahydrate (1 mg/1) + Nicotinamide (10 mg/1) + Omega-3 fatty acids (75 1/1) + Calcium pantothenate (5 mg/1) + Pyridoxine hydrochloride (2.5 mg/1) + Riboflavin (.85 mg/1) + Sodium selenite (.0325 mg/1) + Thiamine mononitrate (1.25 mg/1) + Zinc (7 mg/1) + alpha-Tocopherol succinate (15 [iU]/1)KitOralMedecor Pharma, Llc2016-05-10Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
948QAQ08I1
CAS number
7631-95-0
InChI Key
TVXXNOYZHKPKGW-UHFFFAOYSA-N
InChI
InChI=1S/Mo.2Na.4O/q;2*+1;;;2*-1
IUPAC Name
disodium dioxomolybdenumbis(olate)
SMILES
[Na+].[Na+].[O-][Mo]([O-])(=O)=O

References

General References
Not Available
KEGG Compound
C15455
ChemSpider
55350
RxNav
36699
ChEBI
75215
Wikipedia
Sodium_molybdate

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount
1, 2CompletedPreventionDeficiency, Vitamin D / Pre-Eclampsia1
Not AvailableRecruitingNot AvailableLong Haul COVID / Long-Haul COVID-19 / Post-Acute COVID-19 / Post-acute COVID-19 (PACS), or "Long COVID" Syndrome1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Solution, concentrateIntravenous
Injection, solutionIntravenous
Injection, solution, concentrateIntravenous
InjectionIntravenous5.33 mcg/ml
Injection, solutionIntravenous drip
SolutionIntravenous5.33 mcg/ml
CapsuleOral
PowderOral
Tablet, film coated
SolutionIntravenous
SolutionIntravenous50 GBq
LiquidOral
Capsule, liquid filledOral
SolutionIntravenous0.053 mg/10ml
TabletOral
Injection, solutionParenteral
KitOral
Tablet, chewableOral
Capsule, liquid filledOral1 mg
SolutionIntraocular; Intravenous
Capsule, gelatin coatedOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-1.8Chemaxon
pKa (Strongest Acidic)-2.3Chemaxon
Physiological Charge-2Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area80.26 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity5.77 m3·mol-1Chemaxon
Polarizability6.04 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at July 09, 2018 20:01 / Updated at October 06, 2020 04:50